SEMMELWEIS UNIVERSITY, DEPARTMENT OF UROLOGY

TOPIC

Urology – Oncology

VISION

Therapy optimization of urothelial cancers.

MISSION

Utilization of biomarkers in urothelial cancers treated with immune checkpoint inhibitors.

SPECIFIC GOALS
  • PROJECT 1: Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
  • PROJECT 2: High pretreatment sPD-L1 is associated with muscle-invasion and shorter survival in upper tract urothelial carcinoma (UTUC): a post hoc analysis of a prospectively collected serum samples.

Progress Reports